Health Ministry: Malaysia transitioning to six-series vaccinations for children


PETALING JAYA: The Health Ministry will transition to a six-series vaccine schedule for children, says Tan Sri Dr Noor Hisham Abdullah.

The Health director-general said that the combination vaccine (hexavalent DTaP-IPV-HepB-Hib), now covers six diseases, namely diphtheria, tetanus, pertussis, polio, Hepatitis B and Haemophilus Influenzae Type B.

"As many as four doses will be administered to each child, at the two months, three months, five months and 18 months stages.

"In addition, the Hepatitis B vaccine that is given after birth will continue. The previous Hepatitis B vaccine given at one month and six months will no longer be required," he said in a statement on Tuesday (Nov 17).

However, parents are still required to send their child for observation at those ages, as stated in their child's health and immunisation record book, he said.

He added that the new schedule would involve fewer injections throughout the vaccination schedule, from seven previously to five.

"With this reduction, it is easier for parents to ensure their children are given the vaccination injections according to the set immunisation schedule," he said.

The Health DG also assured the vaccines given are safe.

"Observations from the WHO showed that up till Oct 20,49 countries have changed to the DTaP-IPV-HepB-Hib six-series vaccine in their respective national immunisation programmes.

"While it has been used at private medical facilities since 2013 in Malaysia and has been proven to be safe, this will be new under the National Immunisation Program at Health Ministry facilities.

"As such the ministry will observe AEFI (adverse events following immunisation) on every child after each dosage.

"Parents should report any adverse effects experienced by their child to medical officers after each injection by returning the reporting form, even if the effect is minor such as a red spot at where the injection was made," he said.

He also said that parents can report the matter directly to the National Pharmaceutical Regulatory Agency via npra.gov.my.

Article type: free
User access status:
Join our Telegram channel to get our Evening Alerts and breaking news highlights
   

Next In Nation

Kudat the 'Bali of Borneo' has great potential for rural tourism
Khairy to head Malaysian delegation at WHA75 in Geneva
Shipping license requirement does not hinder undersea cable projects, says Dr Wee
Shah Alam student dies in motorcycle crash
More new faces to be fielded in GE15, says Loke
Anti-Drug Agency to add 110 officers to Mobile Recovery Treatment teams
Compulsory medical inspections on all Sabah livestock to curb FMD
Cops hunting for man who dumped religious idol in rubbish bin
Growth of palm oil stockpile not a cause for concern: Zuraida
First person charged under Whistleblower Protection Act acquitted

Others Also Read